ATA980275A - Verfahren zur herstellung eines schuetzenden antigens von bordetella pertussis - Google Patents

Verfahren zur herstellung eines schuetzenden antigens von bordetella pertussis

Info

Publication number
ATA980275A
ATA980275A AT980275A AT980275A ATA980275A AT A980275 A ATA980275 A AT A980275A AT 980275 A AT980275 A AT 980275A AT 980275 A AT980275 A AT 980275A AT A980275 A ATA980275 A AT A980275A
Authority
AT
Austria
Prior art keywords
preparation
bordetella pertussis
protective antigen
antigen
protective
Prior art date
Application number
AT980275A
Other languages
English (en)
Other versions
AT355203B (de
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of ATA980275A publication Critical patent/ATA980275A/de
Application granted granted Critical
Publication of AT355203B publication Critical patent/AT355203B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT980275A 1974-12-24 1975-12-23 Verfahren zur herstellung eines schuetzenden antigens von bordetella pertussis AT355203B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2461439A DE2461439C3 (de) 1974-12-24 1974-12-24 Verfahren zur Herstellung eines schützenden Antigens von Bordetella Pertussis sowie jenes enthaltendes Mittel

Publications (2)

Publication Number Publication Date
ATA980275A true ATA980275A (de) 1979-07-15
AT355203B AT355203B (de) 1980-02-25

Family

ID=5934586

Family Applications (1)

Application Number Title Priority Date Filing Date
AT980275A AT355203B (de) 1974-12-24 1975-12-23 Verfahren zur herstellung eines schuetzenden antigens von bordetella pertussis

Country Status (17)

Country Link
US (1) US4029766A (de)
JP (1) JPS6222970B2 (de)
AT (1) AT355203B (de)
BE (1) BE837082A (de)
CA (1) CA1059027A (de)
CH (1) CH628246A5 (de)
DE (1) DE2461439C3 (de)
DK (1) DK143317C (de)
ES (1) ES443624A1 (de)
FR (1) FR2295758A1 (de)
GB (1) GB1537849A (de)
IE (1) IE42622B1 (de)
IL (1) IL48730A (de)
LU (1) LU74088A1 (de)
MX (1) MX3785E (de)
NL (1) NL7514858A (de)
SE (1) SE431057B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2393065A1 (fr) * 1977-05-31 1978-12-29 Merieux Inst Procede de separation de lipides d'endotoxines bacteriennes et notamment d'endotoxine de bordetella pertussis
US4275000A (en) * 1977-08-22 1981-06-23 National Research Development Corporation Peptide macromolecular complexes
US4196192A (en) * 1977-10-28 1980-04-01 American Cyanamid Company Combined Haemophilus influenzae type b and pertussis vaccine
NZ188211A (en) * 1977-10-28 1984-09-28 American Cyanamid Co Isolation of polyribosyl ribitol phosphate(prp)from haemophilus influenzae type b;vaccine comprising prp and bordetellapertussis antigens
DE2961293D1 (en) * 1978-02-17 1982-01-14 Nat Res Dev Immunogenic cell envelope preparations
US4247452A (en) * 1978-03-01 1981-01-27 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Purification of pertussis haemagglutinins
DE3043291A1 (de) * 1980-11-17 1982-07-01 Dso Pharmachim Vakzine gegen keuchhusten
GB2144129B (en) * 1981-08-24 1985-10-09 Vilas V Likhite Antigens as immunostimulant adjuvants
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
US4705686A (en) * 1986-05-09 1987-11-10 American Cyanamid Process for the preparation of acellular Bordetalla pertussis vaccine
US4845036A (en) * 1987-02-03 1989-07-04 The United States Of America As Represented By The Department Of Health And Human Services Process for isolation of the B oligomer of pertussis toxin
US5139776A (en) * 1987-04-24 1992-08-18 The Research Foundation For Microbial Diseases Of Osaka University Method for culturing Bordetella pertussis, a pertussis toxoid and a pertussis vaccine
CA1337859C (en) * 1987-04-24 1996-01-02 Masashi Chazono Method for culturing bordetella pertussis, a pertussis toxoid and a pertussis vaccine
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
CN101784655A (zh) * 2007-04-27 2010-07-21 菲尼克斯股份有限公司 可溶性重组二十面体病毒样颗粒的改良生成和体内装配

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3141824A (en) * 1961-05-19 1964-07-21 Lilly Co Eli Pertussis antigen
US3395219A (en) * 1964-12-11 1968-07-30 Merck & Co Inc Process for production of pertussis antigen
US3405218A (en) * 1965-09-22 1968-10-08 Parke Davis & Co Extracting bordetella pertussis antigens with lithium bromide
US3465078A (en) * 1965-10-21 1969-09-02 Sydney Z Spiesel Method of recovering antigens from bordetella pertussis cells

Also Published As

Publication number Publication date
JPS6222970B2 (de) 1987-05-20
IL48730A (en) 1978-10-31
DE2461439C3 (de) 1980-03-20
AT355203B (de) 1980-02-25
ES443624A1 (es) 1977-04-16
US4029766A (en) 1977-06-14
FR2295758B1 (de) 1979-06-29
JPS5188623A (de) 1976-08-03
DK143317B (da) 1981-08-10
DK143317C (da) 1981-12-28
MX3785E (es) 1981-07-16
IE42622L (en) 1976-06-24
DE2461439A1 (de) 1976-07-01
IL48730A0 (en) 1976-02-29
FR2295758A1 (fr) 1976-07-23
NL7514858A (nl) 1976-06-28
LU74088A1 (de) 1976-11-11
CH628246A5 (de) 1982-02-26
BE837082A (fr) 1976-06-24
GB1537849A (en) 1979-01-04
CA1059027A (en) 1979-07-24
DK586575A (da) 1976-06-25
SE431057B (sv) 1984-01-16
DE2461439B2 (de) 1979-07-12
SE7514601L (sv) 1976-06-25
AU8780875A (en) 1977-06-30
IE42622B1 (en) 1980-09-10

Similar Documents

Publication Publication Date Title
AT350798B (de) Verfahren zur herstellung eines verbundstoffes
ATA980275A (de) Verfahren zur herstellung eines schuetzenden antigens von bordetella pertussis
AT343628B (de) Verfahren zur herstellung neuer 1-hydroxyphenyl-2- (3',4'-dimethoxyphenathylamino) athanole-(1)
PT65443B (de) Verfahren zur herstellung von tertiaren aliphatischen aminen
AT363569B (de) Verfahren zur herstellung eines tantal-duennschichtkondensators
DD131019A5 (de) Verfahren zur herstellung eines 2-desoxystreptaminaminoglycosides
ATA845575A (de) Verfahren zur herstellung neuer substituierter benzophenone
AT341774B (de) Verfahren zur herstellung eines copolymerisationsproduktes
AT363590B (de) Verfahren zur stimulierung der immunologischen reaktivitaet eines antigens
AT345961B (de) Verfahren zur herstellung eines reaktions- mittel zur entfernung von phosphationen
AT338749B (de) Verfahren zur herstellung neuer n-alken-(1)-yl-(1)-monohalogenacetamide
DD129783A5 (de) Verfahren zur herstellung eines enons
AT332538B (de) Verfahren zur herstellung eines 7beta-aminocephalosporins
AT367386B (de) Verfahren zur herstellung eines silizium-aluminium-oxynitrid enthaltenden keramischen materiales
AT349293B (de) Verfahren zur herstellung eines tee-extraktes
AT347316B (de) Verfahren zur herstellung eines kapsel- empfindlichen gelierten sprengstoffes
AT340551B (de) Verfahren zur herstellung eines hartbaren klebfilms
AT347138B (de) Verfahren zur herstellung eines sich zur umwandlung von groessen eignenden materials
AT296500B (de) Verfahren zur Herstellung eines ein Antigen und ein Adjuvans enthaltenden Impfstoffes
AT344329B (de) Verfahren zur herstellung von antigenen
AT349159B (de) Verfahren zur herstellung neuer bufadienolid- und bufatrienolidaether
AT297219B (de) Verfahren zur Herstellung eines Staupeimpfstoffes
ATA775675A (de) Verfahren zur herstellung eines antilipoid-a-serums
ATA881777A (de) Verfahren zur immunologischen bestimmung eines antigens
AT346325B (de) Verfahren zur herstellung neuer thiazolidon- oder oxazolidonderivate

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee